Silexion Therapeutics Corp Ordinary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
SLXN Company Description
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.
SLXN Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view SLXN Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of SLXN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SLXN's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of SLXN in WallStreetBets Daily Discussion
SLXN News
Recent insights relating to SLXN
CNBC Recommendations
Recent picks made for SLXN stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in SLXN
Corporate Flights
Flights by private jets registered to SLXN
Our Analysis